ANDA 60736, held by Sun Pharm Industries. Tetracycline Hydrochloride.
As of Nov 16, 2026, ANDA 60736 (Tetracycline Hydrochloride), held by Sun Pharm Industries, was first approved by FDA on Feb 7, 1980, with 11 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 7, 1980 | Original application | Approved | None posted |
| Tetracycline Hydrochloride250MG · capsule;oral | Tetracycline Hydrochloride | Discontinued |
| Tetracycline Hydrochloride500MG · capsule;oral | Tetracycline Hydrochloride | Discontinued |
| Mar 31, 2025 | Supplement 26Labeling · Standard review | Approved | None posted |
| Jul 24, 2002 | Supplement 23Manufacturing | Approved | None posted |
| Feb 8, 2002 | Supplement 22Manufacturing | Approved | None posted |
| Nov 2, 2001 | Supplement 20Manufacturing | Approved | None posted |
| Sep 24, 2001 | Supplement 21Manufacturing | Approved | None posted |
| Dec 18, 2000 | Supplement 16Manufacturing | Approved | None posted |
| Dec 18, 2000 | Supplement 17Manufacturing | Approved | None posted |
| Dec 18, 2000 | Supplement 18Manufacturing | Approved | None posted |
| Dec 18, 2000 | Supplement 19Manufacturing | Approved | None posted |
| May 1, 1992 | Supplement 15Labeling | Approved | None posted |
| Jan 22, 1992 | Supplement 14Labeling | Approved | None posted |
| Feb 7, 1980 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters